Use of a Probiotic to Enhance Iron Absorption in a Randomized Trial of Pediatric Patients Presenting with Iron Deficiency

Gerald M. Rosen, Sue Morrissette, Amy Larson, Pam Stading, Kristen H. Griffin, Timothy L. Barnes

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate the efficacy of low dose ferrous sulfate for the treatment of iron deficiency and if the probiotic Lactobacillus plantarum 299v (LP299v) enhances treatment. Study design: This randomized, double-blinded, controlled trial of the treatment of iron deficiency in children compared the use of low-dose ferrous sulfate (1-3 mg/kg/day), with or without probiotic (LP299v). Results: Serum ferritin level increased in all children from a baseline of 23.7 ng/mL to 45.4 ng/mL after 6-8 weeks of treatment. There was no significant difference in the increase in serum ferritin in children taking the probiotic LP299v compared with controls (23.2 vs 20.0 ng/mL, respectively). Additionally, an increase in ferritin level was not significantly associated with probiotic use when controlling for other factors, including child weight and dosing. Overall, the treatments were well-tolerated, with mild side effects. Conclusions: Treatment with low-dose ferrous sulfate is well-tolerated and effective in correcting iron deficiency in children. However, the probiotic LP299v did not enhance treatment. Further attention should examine the dose–response effect in children, including an alternate day dosing schedule. Trial registration: ClinicalTrials.gov: NCT01617044.

Original languageEnglish (US)
Pages (from-to)192-197.e1
JournalJournal of Pediatrics
Volume207
DOIs
StatePublished - Apr 1 2019

Fingerprint

Probiotics
ferrous sulfate
Iron
Lactobacillus plantarum
Pediatrics
Ferritins
Therapeutics
Serum
Appointments and Schedules
Weights and Measures

Keywords

  • adolescents
  • children
  • supplements

Cite this

Use of a Probiotic to Enhance Iron Absorption in a Randomized Trial of Pediatric Patients Presenting with Iron Deficiency. / Rosen, Gerald M.; Morrissette, Sue; Larson, Amy; Stading, Pam; Griffin, Kristen H.; Barnes, Timothy L.

In: Journal of Pediatrics, Vol. 207, 01.04.2019, p. 192-197.e1.

Research output: Contribution to journalArticle

Rosen, Gerald M. ; Morrissette, Sue ; Larson, Amy ; Stading, Pam ; Griffin, Kristen H. ; Barnes, Timothy L. / Use of a Probiotic to Enhance Iron Absorption in a Randomized Trial of Pediatric Patients Presenting with Iron Deficiency. In: Journal of Pediatrics. 2019 ; Vol. 207. pp. 192-197.e1.
@article{c65e576ac2d04533bbc0d1e2cbf4d352,
title = "Use of a Probiotic to Enhance Iron Absorption in a Randomized Trial of Pediatric Patients Presenting with Iron Deficiency",
abstract = "Objective: To evaluate the efficacy of low dose ferrous sulfate for the treatment of iron deficiency and if the probiotic Lactobacillus plantarum 299v (LP299v) enhances treatment. Study design: This randomized, double-blinded, controlled trial of the treatment of iron deficiency in children compared the use of low-dose ferrous sulfate (1-3 mg/kg/day), with or without probiotic (LP299v). Results: Serum ferritin level increased in all children from a baseline of 23.7 ng/mL to 45.4 ng/mL after 6-8 weeks of treatment. There was no significant difference in the increase in serum ferritin in children taking the probiotic LP299v compared with controls (23.2 vs 20.0 ng/mL, respectively). Additionally, an increase in ferritin level was not significantly associated with probiotic use when controlling for other factors, including child weight and dosing. Overall, the treatments were well-tolerated, with mild side effects. Conclusions: Treatment with low-dose ferrous sulfate is well-tolerated and effective in correcting iron deficiency in children. However, the probiotic LP299v did not enhance treatment. Further attention should examine the dose–response effect in children, including an alternate day dosing schedule. Trial registration: ClinicalTrials.gov: NCT01617044.",
keywords = "adolescents, children, supplements",
author = "Rosen, {Gerald M.} and Sue Morrissette and Amy Larson and Pam Stading and Griffin, {Kristen H.} and Barnes, {Timothy L.}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.jpeds.2018.12.026",
language = "English (US)",
volume = "207",
pages = "192--197.e1",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Use of a Probiotic to Enhance Iron Absorption in a Randomized Trial of Pediatric Patients Presenting with Iron Deficiency

AU - Rosen, Gerald M.

AU - Morrissette, Sue

AU - Larson, Amy

AU - Stading, Pam

AU - Griffin, Kristen H.

AU - Barnes, Timothy L.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Objective: To evaluate the efficacy of low dose ferrous sulfate for the treatment of iron deficiency and if the probiotic Lactobacillus plantarum 299v (LP299v) enhances treatment. Study design: This randomized, double-blinded, controlled trial of the treatment of iron deficiency in children compared the use of low-dose ferrous sulfate (1-3 mg/kg/day), with or without probiotic (LP299v). Results: Serum ferritin level increased in all children from a baseline of 23.7 ng/mL to 45.4 ng/mL after 6-8 weeks of treatment. There was no significant difference in the increase in serum ferritin in children taking the probiotic LP299v compared with controls (23.2 vs 20.0 ng/mL, respectively). Additionally, an increase in ferritin level was not significantly associated with probiotic use when controlling for other factors, including child weight and dosing. Overall, the treatments were well-tolerated, with mild side effects. Conclusions: Treatment with low-dose ferrous sulfate is well-tolerated and effective in correcting iron deficiency in children. However, the probiotic LP299v did not enhance treatment. Further attention should examine the dose–response effect in children, including an alternate day dosing schedule. Trial registration: ClinicalTrials.gov: NCT01617044.

AB - Objective: To evaluate the efficacy of low dose ferrous sulfate for the treatment of iron deficiency and if the probiotic Lactobacillus plantarum 299v (LP299v) enhances treatment. Study design: This randomized, double-blinded, controlled trial of the treatment of iron deficiency in children compared the use of low-dose ferrous sulfate (1-3 mg/kg/day), with or without probiotic (LP299v). Results: Serum ferritin level increased in all children from a baseline of 23.7 ng/mL to 45.4 ng/mL after 6-8 weeks of treatment. There was no significant difference in the increase in serum ferritin in children taking the probiotic LP299v compared with controls (23.2 vs 20.0 ng/mL, respectively). Additionally, an increase in ferritin level was not significantly associated with probiotic use when controlling for other factors, including child weight and dosing. Overall, the treatments were well-tolerated, with mild side effects. Conclusions: Treatment with low-dose ferrous sulfate is well-tolerated and effective in correcting iron deficiency in children. However, the probiotic LP299v did not enhance treatment. Further attention should examine the dose–response effect in children, including an alternate day dosing schedule. Trial registration: ClinicalTrials.gov: NCT01617044.

KW - adolescents

KW - children

KW - supplements

UR - http://www.scopus.com/inward/record.url?scp=85060943556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060943556&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2018.12.026

DO - 10.1016/j.jpeds.2018.12.026

M3 - Article

VL - 207

SP - 192-197.e1

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

ER -